Total Payments
$338,027
2024 Payments
$22,697
Companies
42
Transactions
926
Medicare Patients
8,626
Medicare Billing
$738,532
Payment Breakdown by Category
Other$259,966 (76.9%)
Travel$46,262 (13.7%)
Food & Beverage$19,734 (5.8%)
Consulting$11,938 (3.5%)
Education$126.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $259,966 | 121 | 76.9% |
| Travel and Lodging | $46,262 | 118 | 13.7% |
| Food and Beverage | $19,734 | 679 | 5.8% |
| Consulting Fee | $11,938 | 3 | 3.5% |
| Education | $126.70 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $143,367 | 311 | $0 (2024) |
| Amarin Pharma Inc. | $136,859 | 209 | $0 (2024) |
| Astellas Pharma US Inc | $28,275 | 52 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $9,795 | 13 | $0 (2019) |
| Novo Nordisk Inc | $9,787 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $3,892 | 19 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,146 | 67 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $747.19 | 31 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $447.71 | 21 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $358.22 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,697 | 99 | Amgen Inc. ($11,159) |
| 2023 | $13,819 | 109 | Amgen Inc. ($12,489) |
| 2022 | $5,811 | 116 | Amgen Inc. ($3,968) |
| 2021 | $9,485 | 93 | Astellas Pharma US Inc ($7,593) |
| 2020 | $20,395 | 51 | Amarin Pharma Inc. ($12,091) |
| 2019 | $162,735 | 237 | Amarin Pharma Inc. ($123,216) |
| 2018 | $60,162 | 120 | Amgen Inc. ($38,317) |
| 2017 | $42,924 | 101 | Amgen Inc. ($42,164) |
All Payment Transactions
926 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $138.33 | General |
| Category: Heart Failure | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.51 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: CARDIOLOGY | ||||||
| 11/25/2024 | Amarin Pharma Inc. | Vascepa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: cardiovascular | ||||||
| 11/22/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: VTE | ||||||
| 11/14/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $90.83 | General |
| Category: VTE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.20 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $13.97 | General |
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $40.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.91 | General |
| 10/24/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: CARDIOLOGY | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $34.27 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $35.56 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/08/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $8.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,133 | 2,608 | $568,455 | $200,708 |
| 2022 | 24 | 2,285 | 2,874 | $585,783 | $203,507 |
| 2021 | 27 | 2,385 | 3,001 | $586,634 | $214,800 |
| 2020 | 28 | 1,823 | 2,246 | $392,896 | $119,517 |
Total Patients
8,626
Total Services
10,729
Medicare Billing
$738,532
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 519 | 936 | $260,208 | $115,771 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 173 | $35,638 | $16,689 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $24,320 | $9,519 | 39.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 138 | 138 | $28,290 | $7,032 | 24.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 51 | $10,302 | $4,783 | 46.4% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 54 | 54 | $18,900 | $4,650 | 24.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 43 | 43 | $22,513 | $4,370 | 19.4% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Facility | 2023 | 70 | 70 | $29,120 | $4,340 | 14.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 367 | 380 | $22,800 | $4,002 | 17.6% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 62 | 62 | $18,104 | $3,946 | 21.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 71 | 71 | $14,555 | $3,682 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $9,950 | $3,356 | 33.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 90 | 90 | $8,280 | $2,490 | 30.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 39 | 39 | $9,204 | $2,285 | 24.8% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Facility | 2023 | 20 | 21 | $6,678 | $1,698 | 25.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,716 | $1,643 | 34.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 27 | 27 | $7,479 | $1,554 | 20.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 14 | 16 | $7,675 | $1,508 | 19.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 38 | 38 | $3,496 | $1,112 | 31.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 104 | 104 | $4,888 | $1,099 | 22.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $4,676 | $1,092 | 23.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 12 | 12 | $3,336 | $768.30 | 23.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 13 | 13 | $3,068 | $719.72 | 23.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 31 | 31 | $3,286 | $708.36 | 21.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 22 | 22 | $1,936 | $615.09 | 31.8% |
About Dr. Vivek Goswami, MD
Dr. Vivek Goswami, MD is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689734113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vivek Goswami, MD has received a total of $338,027 in payments from pharmaceutical and medical device companies, with $22,697 received in 2024. These payments were reported across 926 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($259,966).
As a Medicare-enrolled provider, Goswami has provided services to 8,626 Medicare beneficiaries, totaling 10,729 services with total Medicare billing of $738,532. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Austin, TX
- Active Since 12/12/2006
- Last Updated 01/24/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1689734113
Products in Payments
- Repatha (Biological) $142,996
- Vascepa (Drug) $136,859
- LEXISCAN (Drug) $14,983
- PRALUENT ALIROCUMAB INJECTION (Biological) $9,853
- PRALUENT (Drug) $3,860
- Ozempic (Drug) $2,517
- LEQVIO (Drug) $772.52
- PRALUENT (Biological) $481.09
- LifeVest (Device) $447.71
- ENTRESTO (Drug) $373.09
- FLOWTRIEVER CATHETER, S (Device) $310.74
- NEXLETOL (Drug) $291.32
- XARELTO (Drug) $277.69
- Impella (Device) $257.73
- ELIQUIS (Drug) $256.69
- Edarbyclor (Drug) $247.08
- EVKEEZA (Biological) $208.06
- CAMZYOS (Drug) $184.40
- Lexiscan (Drug) $181.46
- BRILINTA (Drug) $167.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Dr. Jason Zagrodzky, M.d, M.D
Cardiovascular Disease — Payments: $953,600
Cardiovascular Disease $953,600
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Cardiovascular Disease $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Cardiovascular Disease $448,847
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010
Cardiovascular Disease $225,010
Jerome Thomas, Md, MD
Cardiovascular Disease — Payments: $163,563
Cardiovascular Disease $163,563